Improvement in hereditary hemorrhagic telangiectasia after treatment with the multi-kinase inhibitor Sunitinib. [electronic resource]
- Annals of hematology Dec 2016
- 2077-2078 p. digital
Publication Type: Case Reports; Letter
1432-0584
10.1007/s00277-016-2796-6 doi
Aged Follow-Up Studies Humans Indoles--therapeutic use Male Protein Kinase Inhibitors--therapeutic use Pyrroles--therapeutic use Sunitinib Telangiectasia, Hereditary Hemorrhagic--diagnosis Treatment Outcome